- Latest available (Revised)
- Original (As made)
The Alternative Investment Fund Managers Regulations 2013, Section 78A is up to date with all changes known to be in force on or before 24 July 2024. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Whole provisions yet to be inserted into this Instrument (including any effects on those provisions):
78A.—(1) If this regulation applies—
(a)an AIF, a EuVECA or a EuSEF (a “relevant fund”) may be marketed in the United Kingdom on the same terms and subject to the same conditions as the relevant fund was, or could have been, marketed in the United Kingdom before [F3IP completion day] until the end of the period determined in accordance with regulation 78C;
(b)an AIFM which is authorised (in accordance with Article 6.1 of the alternative investment fund managers directive) by its home state regulator (“an EEA AIFM”) may continue to market a UK AIF in the United Kingdom on the same terms and subject to the same conditions as it was able to do before [F3IP completion day] until the end of the period determined in accordance with regulation 78C.
(2) This regulation applies in relation to AIFs where—
(a)an EEA AIFM satisfied the conditions entitling it to market an EEA AIF in the United Kingdom before [F3IP completion day] under regulation 49;
(b)the entitlement to market that AIF has not been suspended or revoked before [F3IP completion day];
(c)the AIFM of the AIF has, before [F3IP completion day], notified the FCA that it wishes the relevant fund to have temporary permission to be marketed in the United Kingdom after [F3IP completion day] under paragraph (1); and
(d)the AIFM is an authorised person, or is authorised or registered as an AIFM in a Member State.
(3) This regulation applies in relation to EuVECAs where—
(a)the EuVECA is—
(i)registered under Article 14a of the EuVECA Regulation (as it applies in the European Union) in a Member State, or
(ii)managed by a small registered UK AIFM or a EuVECA Manager;
(b)the FCA has, before [F3IP completion day], received a notification under Article 16 of the EuVECA Regulation that the United Kingdom has been added to the list of Member States in which the manager intends to market the EuVECA;
(c)the AIFM or EuVECA Manager of the EuVECA—
(i)has not been subject to any sanctions under Article 18 of the EuVECA Regulation, and
(ii)has notified the FCA that it wishes the relevant fund to have temporary permission to be marketed in the United Kingdom after [F3IP completion day] under paragraph (1).
(4) This regulation applies in relation to EuSEFs where—
(a)the EuSEF is—
(i)registered under Article 15a of the EuSEF Regulation (as it applies in the European Union), or
(ii)managed by a small registered UK AIFM or a EuSEF Manager;
(b)the FCA has, before [F3IP completion day], received a notification under Article 17 of the EuSEF Regulation that the United Kingdom has been added to the list of Member States in which the manager intends to market the EuSEF;
(c)the AIFM or EuSEF Manager marketing the relevant fund—
(i)has not been subject to any sanctions under Article 19 of the EuSEF Regulation, and
(ii)has notified the FCA that it wishes the relevant fund to have temporary permission to be marketed in the United Kingdom after [F3IP completion day] under paragraph (1).
(5) This regulation applies in relation to EEA AIFMs marketing UK AIFs where the EEA AIFM—
(a)satisfied the conditions entitling it to market the UK AIF in the United Kingdom before [F3IP completion day] under regulation 49;
(b)is authorised or registered as an AIFM in a Member State;
(c)has notified the FCA that it wishes to have temporary permission to market the UK AIF in the United Kingdom after [F3IP completion day] under paragraph (1).
(6) For the purposes of paragraphs (2)(c), (3)(c)(ii), (4)(c)(ii) and (5)(c), the notification must—
(a)be made in such manner, and during such period, and
(b)contain, or be accompanied by, such information,
as the FCA may direct.
(7) The power to give a direction under this regulation includes the power—
(a)to give different directions to different persons or categories of person;
(b)to vary or revoke a previous direction.]]
Textual Amendments
F1Regulations revoked (14.12.2023 for the revocation of reg. 79) by Financial Services and Markets Act 2023 (c. 29), s. 86(3), Sch. 1 Pt. 2 (with s. 1(4)); S.I. 2023/1382, reg. 2(c)(vi)
F2Pt. 9A inserted (20.2.2019) by The Alternative Investment Fund Managers (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/328), regs. 1(2), 14 (as amended by S.I. 2019/325, reg. 58)
F3Words in reg. 78A substituted (31.1.2020 immediately before exit day) by The Financial Services (Consequential Amendments) Regulations 2020 (S.I. 2020/56), regs. 1, 3(a)
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: